Growth Metrics

Sanofi (SNY) Amortization (2016 - 2026)

Sanofi's Amortization history spans 18 years, with the latest figure at $2.7 billion for Q1 2026.

  • On a quarterly basis, Amortization rose 13.92% to $2.7 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $25.6 billion, a 45.02% increase, with the full-year FY2025 number at $83.5 billion, changed 0.33% from a year prior.
  • Amortization hit $2.7 billion in Q1 2026 for Sanofi, down from $11.1 billion in the prior quarter.
  • Over the last five years, Amortization for SNY hit a ceiling of $86.0 billion in Q3 2025 and a floor of $2.1 billion in Q1 2024.
  • Historically, Amortization has averaged $15.0 billion across 5 years, with a median of $6.6 billion in 2024.
  • Biggest five-year swings in Amortization: decreased 28.45% in 2024 and later surged 2194.81% in 2025.
  • Tracing SNY's Amortization over 5 years: stood at $2.2 billion in 2022, then skyrocketed by 347.05% to $9.8 billion in 2023, then dropped by 2.48% to $9.5 billion in 2024, then increased by 16.79% to $11.1 billion in 2025, then crashed by 76.17% to $2.7 billion in 2026.
  • Business Quant data shows Amortization for SNY at $2.7 billion in Q1 2026, $11.1 billion in Q4 2025, and $86.0 billion in Q3 2025.